Eibl, H. Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society;
Sindermann, H., Croft, S. L., Engel, K. R., Bommer, W., Eibl, H., Unger, C., et al. (2003). Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology, online: 10.1007/s00430-003-0201-2. Retrieved from http://www.springerlink.com/content/qhh4kh9a38137u6h/fulltext.pdf.